Call Options

10 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$7.86 - $12.91 $11,004 - $18,074
-1,400 Reduced 11.67%
10,600 $92,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $13.97 $1,412 - $2,794
200 Added 1.69%
12,000 $100,000
Q1 2022

May 16, 2022

BUY
$12.15 - $35.28 $64,395 - $186,984
5,300 Added 81.54%
11,800 $153,000
Q4 2021

Feb 14, 2022

BUY
$30.49 - $48.49 $198,185 - $315,185
6,500 New
6,500 $222,000
Q4 2019

Feb 12, 2020

SELL
$18.96 - $29.84 $274,920 - $432,680
-14,500 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$19.12 - $26.24 $277,240 - $380,480
14,500 New
14,500 $277,000
Q2 2019

Aug 20, 2019

SELL
$19.57 - $24.1 $193,743 - $238,590
-9,900 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$12.14 - $20.46 $112,902 - $190,278
-9,300 Reduced 48.44%
9,900 $203,000
Q4 2018

Feb 14, 2019

SELL
$11.24 - $18.5 $4,496 - $7,400
-400 Reduced 2.04%
19,200 $233,000
Q3 2018

Nov 14, 2018

BUY
$12.5 - $15.38 $245,000 - $301,448
19,600 New
19,600 $301,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.77B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.